Becker Capital Management Inc Novo Nordisk A S Transaction History

Becker Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $46,437 - $56,713	-390 Reduced 16.62%	1,957 $233,000
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $46,460 - $61,843	-455 Reduced 16.24%	2,347 $301,000
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $28,967 - $34,798	-330 Reduced 10.54%	2,802 $289,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $142,412 - $312,479	1,566 Added 100.0%	3,132 $284,000
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $244,264 - $270,369	1,566 New	1,566 $253,000

1,873

336M

9.21M

8.57M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $176B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Becker Capital Management Inc with notifications on news.